Meglič L

No ORCID on file · 2 papers in corpus · active 2023-2026
2026
Thymidine kinase as a biomarker of chemoresistance in epithelial ovarian cancer using the KELIM model.
Frontiers in pharmacology ·doi:10.3389/fphar.2026.1617484

BackgroundOvarian cancer (OC) remains the most lethal gynecological malignancy, with platinum sensitivity being a key determinant of treatment outcomes. The KELIM model, derived from CA-125 kinetics, is a promising biomarker for predicting …

2023
A Dual Biomarker TK1 Protein and CA125 or HE4-Based Algorithm as a Better Diagnostic Tool than ROMA Index in Early Detection of Ovarian Cancer.
Cancers ·doi:10.3390/cancers15051593

BackgroundThe early detection of ovarian cancer is presently not effective, and it is crucial to establish biomarkers for the early diagnosis of ovarian cancer to improve the survival of patients.Materials and methodsThe aim of this study w…